Ceftobiprole Medocaril

Records for this ingredient, by country (identity only).

ATC J01DI01 · 4 markets · 4 records

Ceftobiprole Medocaril 4 markets · 4 records Forms
Filters

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 667 mg per mL / per unit basis not statedinjectionZEVTERA

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength · includes records with unknown status (not proof of sale)

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 666.6 mg per mL / per unit basis not statedinjectionMABELIO 500 mg, poudre pour solution à diluer pour solution pour perfusion

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.